# Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol

> **NCT00679042** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **CellTrans Inc.** · enrollment: 21 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** Islets of Langerhans transplantation

## Key facts

- **NCT ID:** NCT00679042
- **Lead sponsor:** CellTrans Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2007-09-05
- **Primary completion:** 2017-07-19
- **Final completion:** 2026-06-14
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00679042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00679042, "Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00679042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*